Preparation and characterization of nano hydroxyapatite sol

Transactions of Nonferrous Metals Society of China (English Edition)

Volumn 14, Issue 1, 2004, Pages 29-32

  Wang, You Fa ^a   Yan, Yu Hua ^a   Ren, Wei ^a   Cao, Xian Ying ^a   Li, Shi Pu ^a  

^a WUHAN UNIVERSITY OF TECHNOLOGY   (China)

Author keywords

Disperse characteristics; Hydroxyapatite; Nano crystal; Stability

Indexed keywords

CALCIUM COMPOUNDS; CELLS; HYDRATED LIME; HYDROXYAPATITE; NANOSTRUCTURED MATERIALS; STABILITY; TISSUE;

INORGANIC BIOMATERIALS; LIVER CANCER CELL; NANO HYDROXYAPATITE SOL;

BIOMATERIALS;

EID: 2942679102     PISSN: 10036326     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. LI Shi-pu. Introduction of Biomedical Materials [M]. Wuhan: Wuhan University of Technology Press, 2000. (in Chinese)
2. Hideki A. Science and Medical Applications of Hydroxyapatite [M]. Tokyo: Japanese Association of Apatite Science, 1992.
3. Cios A, Mycek B P. The kinetics of pentoxifylline release in vivo from drug-loaded hydroxyapatite implants [J]. Ceramics International, 2001, 27(7): 767-772
4. Itokazu M, Esaki M. Local drug delivery system using ceramics: vacuum method for impregnating a chemo-therapeutic agent into a porous hydroxyapatite block [J]. Journal of Materials Science: Materials in Medicine, 1999, 10(4): 249-252.
5. Nordstrom T, Senkas A, Eriksson S, et al. Generation of a new protein purification matrix by loading ceramic hydroxyapatite with metal ions-demonstration with poly-histidine tagged green fluorescent protein [J]. Journal of Biotechnology, 1999, 69(2): 125-133.
6. ZHANG Li-de, MOU Ji-mei. Nano Materials and Nano Structure [M]. Beijing: Science Press, 2001. (in Chinese)
7. Liu Q, de Wijn R, de Groot K, et al. Surface modification of nanoapatite by grafting organic polymer [J]. Biomaterials, 1998, 19(11-12): 1067-1072.
8. Siegel R W. Creating nanophase materials [J]. Scientific American, 1996, 275(6): 42-47.
9. Nadrian C S. In the nick of space: generalized nucleic acid complementarity and DNA nanotechnology [J]. Synlett, 2000, 11. 1536-1548.
10. Seeman N C. DNA nanotechnology: Novel DNA constructions [J]. Annu Rev Biophy Biomol Struct, 1998, 27: 225-248.
11. David S S. Biomedical applications of nanotechnology-implications for drug targeting and gene therapy [J]. Trends in Biotechnology, 1997, 15(6): 217-224.
12. Marja H, Seppo Y H. Gene therapy for the treatment of peripheral vascular disease and coronary artery disease [J]. Drugs of Today, 2000, 36(9): 609-617.
13. Guetens G, Van C K. Nanotechnology in bio/clinical analysis [J]. Journal of Chromatography Biomedical Applications, 2000, 739(1): 139-150.
14. Deb S, Wang M, Tanner K E, et al. Hydroxyapatite-polyethylene composite: Effect of grafting and surface treatment of hydroxyapatite [J]. J of Mater Sci: Mater in Med, 1996, 7(4): 191-193.
15. Hideki A. Hydroxyapatite [M]. Tokyo: Ishiyako Publishers, Inc, 1999. (in Japanese)
16. Willie M U D, Jacobus H. The role of the MAP-Kinase superfamily in β-amyloid toxicity [J]. Metabolic brain disease, 2001, 16(3-4): 175-185.
17. WANG Hong-hui. The Effect of HAP Nanoparticles on the Hepatocellular Carcinoma Cell and its Telomerase Gene Expression [D]. Wuhan: Wuhan University of Technology, 2003. (in Chinese)